Edap Tms (NASDAQ:EDAP) Cut to Sell at StockNews.com

StockNews.com lowered shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a research note issued to investors on Friday.

Separately, HC Wainwright lifted their target price on shares of Edap Tms from $16.00 to $19.00 and gave the company a buy rating in a research report on Monday, April 1st.

Edap Tms Trading Down 2.7 %

Shares of Edap Tms stock opened at $7.14 on Friday. Edap Tms has a 1 year low of $3.60 and a 1 year high of $12.23. The firm has a market cap of $264.89 million, a PE ratio of -11.33 and a beta of 0.65. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.84 and a quick ratio of 2.30. The company has a 50 day simple moving average of $7.34 and a two-hundred day simple moving average of $6.29.

Edap Tms (NASDAQ:EDAP) last announced its earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.13). Edap Tms had a negative net margin of 35.03% and a negative return on equity of 34.33%. The company had revenue of $21.27 million for the quarter, compared to the consensus estimate of $21.30 million. Analysts expect that Edap Tms will post -0.36 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

Hedge funds have recently made changes to their positions in the business. Milestone Investment Advisors LLC bought a new stake in shares of Edap Tms in the 3rd quarter worth approximately $39,000. Rock Springs Capital Management LP lifted its holdings in shares of Edap Tms by 14.6% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock worth $9,547,000 after acquiring an additional 173,700 shares during the last quarter. Summit Trail Advisors LLC bought a new stake in shares of Edap Tms in the 3rd quarter worth approximately $77,000. Finally, Miracle Mile Advisors LLC bought a new stake in shares of Edap Tms in the 1st quarter worth approximately $136,000. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.